Free tool
FAERS Monitor: Lipitor
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 020702 or its brand name (Lipitor, Atorvastatin Calcium). Reports on generic versions are filed under their own applications.
Reports
248,656
Serious
160,978
65% of reports
Hospitalization
70,773
Death reported
18,815
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- fatigue14,464
- drug ineffective13,345
- nausea12,922
- diarrhoea11,692
- dyspnoea11,668
- type 2 diabetes mellitus11,263
- pain10,427
- headache10,307
- dizziness10,189
- myalgia10,017
- asthenia9,153
- arthralgia8,830
- pain in extremity8,371
- fall8,134
- death7,725
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 5,709 |
| 2005 | 7,580 |
| 2006 | 8,146 |
| 2007 | 6,977 |
| 2008 | 6,528 |
| 2009 | 7,351 |
| 2010 | 14,619 |
| 2011 | 11,544 |
| 2012 | 13,815 |
| 2013 | 10,592 |
| 2014 | 15,345 |
| 2015 | 15,342 |
| 2016 | 14,718 |
| 2017 | 12,745 |
| 2018 | 12,859 |
| 2019 | 13,144 |
| 2020 | 12,183 |
| 2021 | 10,534 |
| 2022 | 10,498 |
| 2023 | 9,454 |
| 2024 | 9,967 |
| 2025 | 10,971 |
| 2026 | 8,029 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,805,503 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| type 2 diabetes mellitusSignal | 11,263 | 42.0 | 41.1 | 300,606 |
| myalgiaSignal | 10,017 | 5.2 | 5.1 | 32,538 |
| pain in extremitySignal | 8,371 | 2.4 | 2.4 | 7,037 |
| fallSignal | 8,134 | 2.1 | 2.0 | 4,607 |
| astheniaSignal | 9,153 | 2.1 | 2.0 | 5,136 |
| arthralgia | 8,830 | 1.8 | 1.8 | 3,217 |
| dyspnoea | 11,668 | 1.8 | 1.7 | 3,846 |
| dizziness | 10,189 | 1.7 | 1.7 | 3,238 |
| fatigue | 14,464 | 1.6 | 1.6 | 3,158 |
| diarrhoea | 11,692 | 1.5 | 1.5 | 2,255 |
| pain | 10,427 | 1.4 | 1.4 | 1,437 |
| headache | 10,307 | 1.4 | 1.4 | 1,179 |
| nausea | 12,922 | 1.4 | 1.4 | 1,428 |
| drug ineffective | 13,345 | 0.9 | 0.8 | 346 |
| death | 7,725 | 0.8 | 0.7 | 627 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.